Cardiac toxicity of molecularly targeted cancer agents is increasingly recognized as a
significant side effect of chemotherapy. These new potent therapies may not only affect the …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

As cancer therapeutics continues to improve and progress, the adverse side effects
associated with anticancer treatments have also attracted more attention and have become …

In the context of modern cancer chemotherapeutics, cancer survivors are living longer and
being exposed to potential comorbidities related to non-cancer side effects of such …

Cardio-oncology is an emerging field that seeks to enhance quality of life and longevity of
cancer survivors. It is pertinent for clinicians to understand the cellular mechanisms of …

Cardiovascular Toxic Effects of Targeted Cancer Therapies | New England Journal of Medicine
Skip to main content Access provided byUT MD ANDERSON CANCER CENTER The New …

Although cardiovascular toxicity from traditional chemotherapies has been well recognized
for decades, the recent explosion of effective novel targeted cancer therapies with …

The quest of defeating cancer and improving prognosis in survivors has generated
remarkable strides forward in research and have advanced the development of new …

Cardiotoxicity is a well-known side-effect described in patients receiving various
antineoplastic agents. With the abundance of clinical research and a heavy focus on drug …